Envestnet Asset Management’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.85M Buy
66,627
+1,071
+2% +$69.7K ﹤0.01% 2230
2026
Q1
$3.12M Buy
65,556
+26,907
+70% +$1.21M ﹤0.01% 2677
2025
Q4
$1.23M Sell
38,649
-11,191
-22% -$349K ﹤0.01% 3151
2025
Q3
$1.4M Buy
49,840
+8,246
+20% +$250K ﹤0.01% 3128
2025
Q2
$1.53M Sell
41,594
-28,685
-41% -$991K ﹤0.01% 3008
2025
Q1
$2.76M Buy
70,279
+15,085
+27% +$679K ﹤0.01% 2518
2024
Q4
$2.56M Buy
55,194
+19,340
+54% +$874K ﹤0.01% 2546
2024
Q3
$1.62M Buy
35,854
+6,015
+20% +$286K ﹤0.01% 2812
2024
Q2
$1.47M Buy
29,839
+5,648
+23% +$230K ﹤0.01% 2780
2024
Q1
$830K Buy
24,191
+7,995
+49% +$289K ﹤0.01% 3152
2023
Q4
$597K Buy
16,196
+138
+0.9% +$3.19K ﹤0.01% 3241
2023
Q3
$325K Sell
16,058
-32,798
-67% -$721K ﹤0.01% 3489
2023
Q2
$1,000K Sell
48,856
-7,373
-13% -$110K ﹤0.01% 2745
2023
Q1
$475K Buy
56,229
+31,376
+126% +$693K ﹤0.01% 3173
2022
Q4
$592K Buy
24,853
+6,481
+35% +$188K ﹤0.01% 2997
2022
Q3
$647K Buy
18,372
+6,092
+50% +$259K ﹤0.01% 2863
2022
Q2
$429K Buy
12,280
+6,380
+108% +$226K ﹤0.01% 3141
2022
Q1
$291K Buy
5,900
+2,653
+82% +$147K ﹤0.01% 3478
2021
Q4
$251K Buy
+3,247
New +$333K ﹤0.01% 3519

Other funds holding TWST

Envestnet Asset Management's TWST Position: Q2 2026 in Review

Envestnet Asset Management increased its Twist Bioscience (TWST) stake by 1.6% in Q2 2026, buying an estimated $69.7K and bringing the position to 66,627 shares worth $6.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2230.

Envestnet Asset Management first reported a position in TWST in Q4 2021 and has held it in 19 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Envestnet Asset Management held 66,627 shares of Twist Bioscience worth $6.85M as of Q2 2026.
  • Envestnet Asset Management bought 1,071 Twist Bioscience shares in Q2 2026, an estimated $69.7K.
  • Twist Bioscience made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #2230 holding.
  • Envestnet Asset Management first reported a position in Twist Bioscience in Q4 2021 and has held it in 19 quarters since.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.